BI
BioAge Labs, Inc. (BIOA)
NASDAQ·Healthcare·Biotechnology
$17.46
-3.32%
Mkt Cap $613.46M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 24, 2026 | $1.40M | $3.08M | +119.86% | -$0.83 | -$0.72 | +13.25% | — | — |
| Q4 2025 Nov 6, 2025 | $1.14M | $2.05M | +80.18% | -$0.67 | -$0.56 | +16.42% | — | — |
| Q3 2025 Aug 6, 2025 | $870.00K | $2.41M | +177.24% | -$0.56 | -$0.60 | -7.14% | — | — |
| Q2 2025 May 6, 2025 | $580.00K | $1.45M | +150.17% | -$0.52 | -$0.36 | +30.77% | — | — |
| Q1 2025 Mar 20, 2025 | $556.67K | — | — | -$0.58 | -$1.97 | -239.66% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.72 | -$6.70 | -830.56% | — | — |
| Q3 2024 Sep 26, 2024 | — | — | — | — | -$1.80 | — | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$1.74 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$2.81 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$1.96 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$2.30 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$1.48 | — | — | — |